Javier Alcácer

Medicine · Health Sciences

11h-index453citations35works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(11), Synthesis and biological activity(9), Lung Cancer Treatments and Mutations(6), Cancer, Hypoxia, and Metabolism(4), Genomics, phytochemicals, and oxidative stress(4)

Publications35 total

Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Table 1 from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Data from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Figure S1-S5 from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Data from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Materials and Method from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Table 1 from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Figure Legends from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Materials and Method from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Figures S1-S6 from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Materials and Methods from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Figure Legend from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Supplementary Figure Legends from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Supplementary Figures S1-S6 from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
2023Open Access
Data from Endothelin-1–Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma
2023Open Access
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice
Molecular Neurobiology·2020· 42 citedOpen Access
Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAFV600E-mutated metastatic melanoma
European Journal of Cancer·2020· 15 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Julián Carretero(24), Inés Pulido(22), Javier Alcácer Fernández-Coronado(22), Fátima Al‐Shahrour(22), Óscar Juan(22), Takeshi Shimamura(22), Margaret Soucheray(21), Jeffrey A. Borgia(21), Agustín Lahoz(21), Jeffrey H. Becker(20), José M. Galbis(14), María L. Rodríguez(13), Aránzazu Lafuente-Sanchis(13), Miguel Aupí(13), Antonio Cremades(13), Amelia Insa(13), Rutu Gandhi(12), Camilla L. Christensen(12), Patricia Simms(12), Hajime Asahina(12)